Discover Great Companies Discover Great Clients
Popularity  2741   |   Likes  2   |   Feedback  1 Claim this company

Research and development of stem cell drugs

No.294 Jiangning District Popularity Ranking Nanjing Jiangsu No.3 He Gan Acids No.5 Yi Xue Ke Yan No.9 Yi Xue Yan Jiu No.21 Innovative Drugs Products No.22 Yuan Yan Yao No.25 Xin Yao R&D No.28 Biological Products No.30 Innovative Drugs No.32 Pharmaceutical R&D No.46 Yao Products R&D No.47 Biopharmaceuticals No.50 Pharmaceutical Technology 科技型中小企业 省民营科技企业 省科技型中小企业 市级创新型中小企业
More

Company Overview

  • Nature: Private Enterprise Size: 50-99 employees Founded: 6年
  • Industry: Pharmaceutical/Bioengineering 、 Diversified Business Group Companies
  • Full name: Jiangsu Ruiyuan Biotechnology Co., Ltd.。

Development Stage

  • Stage: A+轮。
  • Ranking: Ranked #3 in Nanjing He Gan Acids Company by popularity Ranked #5 in Nanjing Yi Xue Ke Yan Company by popularity Ranked #9 in Nanjing Yi Xue Yan Jiu Company by popularity
  • Honors: 科技型中小企业 省民营科技企业 According to algorithm
  • Salary: 42.3% of positions earn 6-10K, In 2026 vs last yeardecreased by 12%.。Master's salary: ¥27.8K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 50%, "Medical & Health/Beauty & Healthcare": 15.4%, "Scientific Research": 7.7%。
  • Recruiting: In 2026 vs 2025grew by 64%. Demand for highly educated talent: Master's: 6.
  • Requirement: Education: 本科 leads with 53.8%. Experience: 不限 leads with 46.2%.
  • Region: Distributed across 1 regions, 南京: 100%.

About the Company

[Summary] Research and development of stem cell drugs

1. Industry Background:
With the rapid development of cell and gene drugs, humanity will enter the era of cell and gene therapy in the 21st century! The Ministry of Science and Technology's key science and technology program "Stem Cell Research and Organ Repair" has funded stem cell therapy research for consecutive years, and multiple departments including the National Health Commission and the National Medical Products Administration have issued documents requiring acceleration of the clinical application of stem cells and regenerative medicine!
Currently, multiple CAR-T therapeutic products have been approved for marketing in China. Our company is mainly engaged in the development of universal stem cell therapeutic drugs, focusing on drug development for immune diseases and refractory diseases, and has obtained multiple registration clinical and IIT clinical approvals.
2. Scale:
The company has completed Phase I construction of a 4,200-square-meter workshop and R&D site, with a total investment exceeding 50 million yuan. It is designed according to the EU's GMP fATMP standards dedicated to cell production, and is equipped with over 300 sets of large instruments and equipment including flow cytometers, QPCR, and cell factory observation stations; the B+A grade real-time microbial monitoring system, isolator preparation technology, one-way personnel and material flow management system, and strict full-process aseptic operation specifications have enabled the preparation and quality control of pharmaceutical-grade cell products!
The company has initiated the planning and construction of Phase II project located in Jiangning High-tech Zone, which will build a headquarters R&D and production base for "advanced therapy medicinal products" represented by cell, nucleic acid, and gene drugs, striving to create a center for cutting-edge drug R&D and translational application in China.
3. Talent Team and Projects:
The company fully practices the principles of R&D-driven and drug development for the people. Academician Wang Guangji of the Chinese Academy of Engineering serves as the company's legal representative and chairman, and multiple professors and scholars have been hired as advisors for pharmaceutical and clinical research, focusing on the druggability research of cell products and the industrial transformation of cell products for treating difficult and severe diseases.
More than 65% of the company's current scientific research team holds master's or doctoral degrees, and the company values employees' continuing education and skill improvement, supporting employees to pursue master's and doctoral studies while employed. As of September 2022, the company has applied for 17 intellectual property rights, with 5 authorized, 3 innovative cell drugs in research, and 2 clinical trials underway, with indications covering major diseases such as active lupus nephritis, refractory lupus nephritis, multiple sclerosis, and diabetic nephropathy (the company obtained registration clinical trial approval in only 2.5 years based on clinical efficacy-based reverse derivation of druggability development).
4. Qualifications:
The company has a New Drug Research Center, GMP Preparation Center, and Clinical Medicine Center, committed to building an international-standard cell product transformation platform, and building cell preparation workshops in accordance with domestic GMP requirements and EU GMP standards.
The company has established clinical research relationships with medical institutions such as Nanjing Drum Tower Hospital, Jiangsu Province Hospital, Subei People's Hospital, and the Affiliated Hospital of Xuzhou Medical University, and has established scientific research cooperation relationships with research institutes such as Nanjing University, China Pharmaceutical University, Nanjing Medical University, and Jiangsu Institute of Nuclear Medicine, and is leading and participating in multiple science and technology programs.
The company has been awarded honors and qualifications such as "Technology-based SME," "Nanjing 2022 Cultivated Unicorn," and "Jiangning High-tech Zone 2021 Three-Star Party Organization," and is a party building contact point for high-level talents in Jiangning District.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Ruiyuan Biotech Financing History (3 rounds)

Manage
A+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 布谷天阙投资

Ruiyuan Biotech How Fast Is Hiring Growing? (17 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 64%
  • 2023: Up 15%
  • 2022: Up 183%
Ruiyuan Biotech Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Ruiyuan Biotech Campus Recruitment & Advanced Degree Talent Demand
Master's 6
Note: How fast is hiring at Jiangsu Ruiyuan Biotechnology Co., Ltd. growing? Ruiyuan Biotech2026: 23 openings (up 64%), 2025: 14 openings (flat), 2024: 14 openings (down 64%), 2023: 39 openings (up 15%), 2022: 34 openings (up 183%), 2021: 12 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Ruiyuan Biotech R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Jiangsu Ruiyuan Biotechnology Co., Ltd.? Based on an analysis of Ruiyuan Biotech's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 50%, "Medical & Health/Beauty & Healthcare": 15.4%, "Scientific Research": 7.7%, "Mechanical/Instrumentation": 3.8%. For reference only.

Ruiyuan Biotech — What Are the Salaries Like? (26 records)

Manage
Ruiyuan Biotech Salary Overview
salary range: 6K - 50K, 42.3% of roles pay ¥6-10K
Note: salary statistics are based on 26 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangsu Ruiyuan Biotechnology Co., Ltd.?Ruiyuan Biotech42.3% of positions earn 6-10K, Undergraduate salary: ¥。Nanjing salary ranking top 20,Biology/Pharmaceutical/Chemical/Environmental Protection average salary ¥17.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Ruiyuan Biotech

(More)
Are salaries high at Jiangsu Ruiyuan Biotechnology Co., Ltd.? We provide: Biopharmaceutical, Sales, Quality, pv, QA, QC, 注册总监, 科学家, 药品注册, Procurement, ehs, 临床, Supply Chain, Vice President, Plant Manager, 合规, 生产计划, Research Director, Research Manager, 细胞培养. Click to view detailed salary analysis by job.

Ruiyuan Biotech honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • Biology/Pharmaceutical/Chemical/Environmental Protection
    50% of total 50%
  • Business Management
    42.3% of total 42.3%
  • Quality Management
    38.5% of total 38.5%
  • Factory Production
    26.9% of total 26.9%

Education

  • 本科
    53.8% of total 53.8%
  • 硕士
    30.8% of total 30.8%
  • 大专
    15.4% of total 15.4%

Experience

  • 不限
    46.2% of total 46.2%
  • 3-5年
    30.8% of total 30.8%
  • 5-10年
    19.2% of total 19.2%
  • 1-3年
    3.8% of total 3.8%
View Detailed Analysis

What does Jiangsu Ruiyuan Biotechnology Co., Ltd. require? Who is Ruiyuan Biotech hiring? Ruiyuan Biotech recruitment: Biology/Pharmaceutical/Chemical/Environmental Protection占比最多占50%,其次是Business Management占42.3%. What education can get in at Ruiyuan Biotech? 本科占比最多占53.8%,其次是硕士占30.8%. High education required at Ruiyuan Biotech? 硕士占30.8%. Work experience required at Ruiyuan Biotech? 不限占比最多占46.2%,其次是3-5年占30.8%. Where are the job locations at Ruiyuan Biotech? 南京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,643.9582万(元)
Legal Representative: 王婧
Date Established:
Credit Code: 91320115MA213NEG05
Registered Address: 南京市江宁区天元东路2289号瑞鸿智汇园4号楼1、2层(江宁高新园)

People who follow Ruiyuan Biotech also follow

Ruiyuan Biotech Competitors (Similar Companies)

医药 生物科技/生物工程 医药工业 动物健康
“An innovative pharmaceutical enterprise engaged in the R&D and industr”
“Committed to becoming a brand supplier of overall solutions for life s”
医药 分子生物学服务 干细胞 细胞免疫治疗
“中枢神经系统疾病新药开发商”
医药 药物研发 生物医药 创新药
“Research, development, and production of anti-tumor and surgical medic”
“Health for Humanity, Creating a Better Future Together”
进出口/国际贸易 跨境电商/外贸 农化/农业化工 中间体
医药 生物医药 原料药 化学原料药
“A renowned enterprise in China's liver disease and anti-tumor fields”
工程总承包/EPC 工程管理 市政工程 消防设施工程
生物科技/生物工程 免疫球蛋白 牛初乳 生命科学
“It is a high-tech pharmaceutical R&D and production enterprise integra”
药物研发 新药研发 临床前研究 临床研究

Discover Great Companies, Discover Great Clients

南京公司名录 南京“Jiangning District”公司名录 南京“新药研发”公司名录 南京“药物研发”公司名录 南京“创新药”公司名录 南京“临床医学”公司名录 南京“医学研究”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates